The bad version of the gene appears to boost osteoporosis risk by limiting the production of the BMP-2 protein, a key molecular stimulator of bone growth, says Dr. Stefansson.
In a study of over 1000 Iceland residents with osteoporosis, the firm found that those with certain bad versions of a gene called BMP-2 were three times more likely to develop osteoporosis.